In order to ensure the rational use of the fund and reduce the medication burden of hepatitis C patients, according to the "Notice on Adjustments to Special Outpatient Categories of Basic Medical Insurance" (Liao Medical Insurance Fa [2022] No. 17), the outpatient special diseases "C

"Antiviral treatment for hepatitis C" and "interferon treatment for hepatitis C" are unified into "chronic hepatitis C".

1. Identification criteria 1. Clinical diagnosis of chronic hepatitis C.

2. Laboratory tests: anti-HCV positive and HCV RNA positive.

2. Payment limit Set the payment limit according to genotype: 1. Basic medical insurance for employees: 9,000 yuan/12 months for genotype 1b, 15,000 yuan/12 months for non-genotype 1b, and the benefit period is 12 months.

2. Basic medical insurance for urban and rural residents: 6,000 yuan/12 months for genotype 1b, 10,000 yuan/12 months for non-genotype 1b, and the benefit period is 12 months.

3. Relevant Matters The outpatient special disease "chronic hepatitis C" is a one-week treatment. The application procedures, reimbursement policies and other related matters shall be implemented in accordance with the basic medical insurance outpatient special disease policies.

If the state or province has other regulations, those regulations shall prevail.